| 1 |
Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data |
|
| | MohammedAyaz Khan, Nahed Sherbini, Sami Alyami, Abdullah Al-Harbi, Majed Al-Ghamdi, Suliman Alrajhi, Rajkumar Rajendram, Hamdan Al-Jahdali | | | Annals of Thoracic Medicine. 2023; 18(1): 45 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Deciding a Treatment Plan for an Older Patient With Severe Idiopathic Pulmonary Fibrosis: A Case Report |
|
| | Yusuke Akashi, Yuta Horinishi, Chiaki Sano, Ryuichi Ohta | | | Cureus. 2023; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk Factors |
|
| | Bianca Beghé, Stefania Cerri, Leonardo M. Fabbri, Alessandro Marchioni | | | International Journal of Molecular Sciences. 2021; 22(17): 9292 | | | [Pubmed] [Google Scholar] [DOI] | |
|
